(HealthDay)—COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how much appears to be driven by the type of underlying condition, new research suggests.
Jul 7, 2021
0
1
Immune rejection is one of the biggest obstacles to cell therapy. To solve this problem, researchers have been investigating iPS cells that have been gene edited so that they can evade the immune system. While this concept ...
Jul 7, 2021
0
0
In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients ...
Jul 1, 2021
0
2
New research led by scientists at La Jolla Institute for Immunology (LJI) and the University of Liverpool may explain why many cancer patients do not respond to anti-PD-1 cancer immunotherapies—also called checkpoint inhibitors.
Jun 24, 2021
0
12
Understanding cellular metabolism—how a cell uses energy—could be key to treating a wide array of diseases, including vascular diseases and cancer.
Jun 18, 2021
0
43
T cells—immune cells that patrol our bodies in search of trouble—have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells themselves as a form of medicine.
Jun 18, 2021
0
4
A team of researchers at Innovative Molecules GmbH, working with several other institutions in Germany, has developed a small-molecule therapy for the treatment of latent herpes simplex virus infections. In their paper published ...
A Ludwig Cancer Research study adds to growing evidence that immune cells known as macrophages inhabiting the body cavities that house our vital organs can aid tumor growth by distracting the immune system's cancer-killing ...
Jun 10, 2021
0
6
Johns Hopkins Medicine researchers recently reported that while two doses of a vaccine against SARS-CoV-2—the virus that causes COVID-19—confers some protection for people who have received solid organ transplants, it ...
Jun 4, 2021
0
20
A new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients, a breakthrough that could extend to the treatment of other cancers. Relatlimab is the first immunotherapy treatment ...
Jun 3, 2021
0
6
